escitalopram 15 MG Oral Capsule

RxCUI
2725159
RxNorm name
escitalopram 15 MG Oral Capsule
Display name
escitalopram 15 MG Oral Capsule
Full name
escitalopram 15 MG Oral Capsule
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:19

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
escitalopramESCITALOPRAMAlmatica Pharma LLCc0401570-a3b0-bef2-7365-c23dc952b8b62025-08-31Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2725159

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
c0401570-a3b0-bef2-7365-c23dc952b8b6escitalopram 15 MG Oral CapsuleSCD1These highlights do not include all the information needed to use ESCITALOPRAM CAPSULES safely and effectively. See full prescribing information for ESCITALOPRAM CAPSULES. ESCITALOPRAM capsules, for oral use Initial U.S. Approval: 200220250831
c0401570-a3b0-bef2-7365-c23dc952b8b6escitalopram 15 MG Oral CapsulePSN1These highlights do not include all the information needed to use ESCITALOPRAM CAPSULES safely and effectively. See full prescribing information for ESCITALOPRAM CAPSULES. ESCITALOPRAM capsules, for oral use Initial U.S. Approval: 200220250831
c0401570-a3b0-bef2-7365-c23dc952b8b6escitalopram (as escitalopram oxalate) 15 MG Oral CapsuleSY1These highlights do not include all the information needed to use ESCITALOPRAM CAPSULES safely and effectively. See full prescribing information for ESCITALOPRAM CAPSULES. ESCITALOPRAM capsules, for oral use Initial U.S. Approval: 200220250831